Hiroaki Mitsuya
Impact in
- Virology top 0.01%
- HIV Research and Treatment
- Infectious Diseases top 0.02%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- SARS-CoV-2 and COVID-19 Research
Papers in
- Virology 267
- HIV Research and Treatment 266
-
- HIV/AIDS drug development and treatment 282
- HIV/AIDS Research and Interventions 79
- SARS-CoV-2 and COVID-19 Research 52
- COVID-19 Clinical Research Studies 31
- Co-authors
- S Broder (28 shared papers)Samuel E. Broder (44 shared papers)Robert Yarchoan (41 shared papers)Arun Kumar Ghosh (83 shared papers)Sandra Nusinoff Lehrman (4 shared papers)David G. Johns (25 shared papers)Robert C. Gallo (5 shared papers)M H St Clair (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (40 papers)Antimicrobial Agents and Chemotherapy (38 papers)Blood (28 papers)Proceedings of the National Academy of Sciences (17 papers)Journal of Virology (17 papers)
- Partner nations
- United StatesJapanMalaysia
In The Last Decade
Hiroaki Mitsuya
553 papers receiving 27.6k citations
Hiroaki Mitsuya's Hit Papers
Peers
Comparison fields: 5 of 177
- Virology 12.3k
- Infectious Diseases 15.8k
- Immunology 4.2k
- Epidemiology 5.1k
- Hepatology 1.1k
Countries citing papers authored by Hiroaki Mitsuya
This map shows the geographic impact of Hiroaki Mitsuya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Mitsuya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Mitsuya more than expected).
Fields of papers citing papers by Hiroaki Mitsuya
This network shows the impact of papers produced by Hiroaki Mitsuya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Mitsuya. The network helps show where Hiroaki Mitsuya may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroaki Mitsuya, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 561 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Hit paper breakdown → | 1985 | 1595 |
| 2 | Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Hit paper breakdown → | 1986 | 1221 |
| 3 | Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides. Hit paper breakdown → | 1986 | 936 |
| 4 | Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development Hit paper breakdown → | 2020 | 783 |
| 5 | ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX Hit paper breakdown → | 1986 | 710 |
| 6 | Molecular Targets for AIDS Therapy Hit paper breakdown → | 1990 | 672 |
| 7 | 1989 | 543 | |
| 8 | Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Hit paper breakdown → | 1987 | 486 |
| 9 | 1987 | 436 | |
| 10 | 1988 | 427 | |
| 11 | 1989 | 392 | |
| 12 | 1984 | 352 | |
| 13 | 1987 | 322 | |
| 14 | 2003 | 321 | |
| 15 | 1986 | 300 | |
| 16 | 2003 | 277 | |
| 17 | 1989 | 271 | |
| 18 | 1989 | 240 | |
| 19 | 1995 | 232 | |
| 20 | 2007 | 224 |
About Hiroaki Mitsuya
Hiroaki Mitsuya is a scholar working on Virology, Infectious Diseases, Immunology, Epidemiology and Hematology, having authored 561 papers that have together received 29.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (282 papers), HIV Research and Treatment (266 papers), HIV/AIDS Research and Interventions (79 papers), T-cell and Retrovirus Studies (52 papers), SARS-CoV-2 and COVID-19 Research (52 papers), Pneumocystis jirovecii pneumonia detection and treatment (46 papers), Cytomegalovirus and herpesvirus research (33 papers) and COVID-19 Clinical Research Studies (31 papers). The work is most often cited by research in Virology (12.3k citations), Infectious Diseases (15.8k citations), Immunology (4.2k citations), Epidemiology (5.1k citations) and Hepatology (1.1k citations). Hiroaki Mitsuya has collaborated with scholars based in United States, Japan and Malaysia. Frequent co-authors include S Broder, Samuel E. Broder, Robert Yarchoan, Arun Kumar Ghosh, Sandra Nusinoff Lehrman, David G. Johns, Robert C. Gallo, M H St Clair, Kent J. Weinhold and Dani P. Bolognesi. Their work appears in journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy, Blood, Proceedings of the National Academy of Sciences and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.